[ET Net News Agency, 29 October 2018] China Resources Double-Crane Pharmaceutical
Company Limited, a 59.99% indirectly owned by China Resources Pharmaceutical Group Limited
(03320) said its net profit increased to RMB863.6 million for the nine months ended 30
September 2018, from RMB755.9 million the same period of the previous year.
Revenue for the period also soared to RMB6,309.5 million from RMB4,756 million a year
earlier. (KL)